GL1X · GenesisL1 explorer

Research workbench

Crystal structure of src kinase domain in complex with covalent inhibitor PD168393

Analyse Crystal structure of src kinase domain in complex with covalent inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2HWP
Type
protein
Length
484 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
DJK
Pockets
6 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein24542% helix, 13% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein23943% helix, 17% strandP00523

Ligands and binding sites

  • DJK · N-[4-(3-bromo-phenylamino)-quinazolin-6-yl]-acrylamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13040.590.7838DJK
23130.550.7630empty
32930.510.7436DJK
4810.410.7812empty
5610.330.7714empty

Interfaces

1 interface between chains.

  • A–B · 338 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 2HWP · Crystal structure of Src kinase domain in complex with covalent inhibitor PD168393 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.